Abstract
The problems involved in the treatment of malignant tumours of the maxillary antrum are described and the need for a disciplined approach emphasised. The overall crude 5-year survival rate for this series of 43 cases was 49%. For the 34 patients suffering from carcinoma the rate was 44%. It is suggested that primary surgery be avoided because in the 23 cases treated by radiotherapy before major surgery the 5-year crude survival rate was 60.8%.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
